T. Rowe Price Associates’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.2M | Buy |
1,924,938
+279,535
| +17% | +$2.5M | ﹤0.01% | 1050 |
|
|
2025
Q4 | $13.9M | Buy |
1,645,403
+507,722
| +45% | +$3.62M | ﹤0.01% | 1157 |
|
|
2025
Q3 | $5.94M | Sell |
1,137,681
-1,738,255
| -60% | -$6.63M | ﹤0.01% | 1350 |
|
|
2025
Q2 | $9.95M | Sell |
2,875,936
-601,855
| -17% | -$1.79M | ﹤0.01% | 1115 |
|
|
2025
Q1 | $9.11M | Buy |
3,477,791
+156,050
| +5% | +$611K | ﹤0.01% | 1132 |
|
|
2024
Q4 | $13.7M | Sell |
3,321,741
-1,958,550
| -37% | -$10.7M | ﹤0.01% | 1076 |
|
|
2024
Q3 | $37.4M | Buy |
5,280,291
+241,276
| +5% | +$1.8M | ﹤0.01% | 831 |
|
|
2024
Q2 | $32.9M | Sell |
5,039,015
-1,840,582
| -27% | -$12.6M | ﹤0.01% | 836 |
|
|
2024
Q1 | $57.1M | Sell |
6,879,597
-1,701,570
| -20% | -$16.6M | 0.01% | 694 |
|
|
2023
Q4 | $94.5M | Sell |
8,581,167
-27,779
| -0.3% | -$234K | 0.01% | 561 |
|
|
2023
Q3 | $72.4M | Buy |
8,608,946
+263,429
| +3% | +$2.83M | 0.01% | 577 |
|
|
2023
Q2 | $105M | Buy |
8,345,517
+1,482,557
| +22% | +$18.4M | 0.01% | 515 |
|
|
2023
Q1 | $113M | Buy |
6,862,960
+2,369,956
| +53% | +$42.5M | 0.02% | 487 |
|
|
2022
Q4 | $67.1M | Sell |
4,493,004
-68,359
| -1% | -$1.31M | 0.01% | 584 |
|
|
2022
Q3 | $102M | Sell |
4,561,363
-738,944
| -14% | -$16.2M | 0.02% | 485 |
|
|
2022
Q2 | $88.8M | Buy |
5,300,307
+300,589
| +6% | +$6.44M | 0.01% | 698 |
|
|
2022
Q1 | $150M | Buy |
4,999,718
+844,377
| +20% | +$20.5M | 0.02% | 615 |
|
|
2021
Q4 | $128M | Buy |
4,155,341
+2,537,388
| +157% | +$80.2M | 0.01% | 694 |
|
|
2021
Q3 | $51M | Buy |
1,617,953
+444,471
| +38% | +$15M | ﹤0.01% | 1003 |
|
|
2021
Q2 | $42.9M | Sell |
1,173,482
-331,610
| -22% | -$10.9M | ﹤0.01% | 1082 |
|
|
2021
Q1 | $52M | Buy |
1,505,092
+731,517
| +95% | +$31.7M | 0.01% | 989 |
|
|
2020
Q4 | $32.1M | Sell |
773,575
-13,927
| -2% | -$630K | ﹤0.01% | 1092 |
|
|
2020
Q3 | $33.5M | Buy |
+787,502
| New | +$30M | ﹤0.01% | 1002 |
|
Other funds holding RLAY
SIAU
CC
CC
PA
BG
VCM
NI
TCM